Integer Holdings Corporation Enhances Capitalization Structure with the Closing of $1.0 Billion Convertible Senior Notes Offering

Core Viewpoint - Integer Holdings Corporation has successfully closed a $1.0 billion offering of 1.875% convertible senior notes due 2030, which is expected to enhance its financial structure and reduce interest expenses, thereby positively impacting adjusted earnings for 2025 [1][2]. Financial Impact - The offering was upsized from an initial $750 million to $875 million due to strong investor demand, with an additional $125 million purchased by initial purchasers [1]. - The transaction is projected to lower interest expenses by approximately $12 million in 2025, contributing to adjusted earnings [2]. - The estimated net proceeds from the offering will be $976.1 million after deducting discounts and expenses, which will be used to pay for capped call transactions, exchange existing convertible notes, and repay outstanding borrowings [2]. Strategic Objectives - The transaction creates revolver capacity, allowing the company to continue its tuck-in acquisition strategy while maintaining a targeted leverage range of 2.5 to 3.5 times adjusted EBITDA [2]. - The structure of the convertible notes includes capped calls that mitigate potential dilution for investors upon conversion [2][3]. Company Overview - Integer Holdings Corporation is a leading medical device contract development and manufacturing organization, serving various markets including cardiac rhythm management and neuromodulation [4]. - The company is committed to providing innovative, high-quality products and solutions to enhance patient lives globally [4].